- Inosine pranobex, effective immunomodulatory drug approved by the long-term clinical application; possible mechanisms of action2018 | Faculty of Medicine in Hradec Králové
- Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course2021 | Third Faculty of Medicine
- Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases2019 | Central Library of Charles University, Third Faculty of Medicine
- Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study2016 | Second Faculty of Medicine
- Data from the first wave of Covid-19 from the Central Military Hospital, Prague, Czech Republic2020 | First Faculty of Medicine
- Inosine Pranobex Significantly Decreased the Case-Fatality Rate among PCR Positive Elderly with SARS-CoV-2 at Three Nursing Homes in the Czech Republic2020 | Third Faculty of Medicine
- Využití léku Isoprinosine v léčbě chronických a recidivujících onemocnění2017 | Publication without faculty affiliation